Pages that link to "Q35167513"

The following pages link to Unique amino acids cluster for switching from the dehydrogenase to oxidase form of xanthine oxidoreductase (Q35167513):

Displaying 32 items.

• Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol (Q24652967) (← links)
• The Mo-Se active site of nicotinate dehydrogenase (Q27646252) (← links)
• The First Mammalian Aldehyde Oxidase Crystal Structure: INSIGHTS INTO SUBSTRATE SPECIFICITY (Q27673709) (← links)
• The role of aldehyde oxidase in drug metabolism (Q28259834) (← links)
• Mycobacterium tuberculosis possesses a functional enzyme for the synthesis of vitamin C, L-gulono-1,4-lactone dehydrogenase (Q28486969) (← links)
• Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant (Q28574692) (← links)
• Biological Chemistry and Functionality of Protein Sulfenic Acids and Related Thiol Modifications (Q29248463) (← links)
• Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. (Q30336517) (← links)
• The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition (Q34330487) (← links)
• Measurement and characterization of superoxide generation from xanthine dehydrogenase: a redox-regulated pathway of radical generation in ischemic tissues (Q34379696) (← links)
• Molybdenum enzymes in higher organisms (Q34812986) (← links)
• The role of reactive oxygen species in microvascular remodeling (Q34836065) (← links)
• Flavin-linked Erv-family sulfhydryl oxidases release superoxide anion during catalytic turnover. (Q35663512) (← links)
• Enzyme Tunnels and Gates As Relevant Targets in Drug Design. (Q36221405) (← links)
• Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance (Q36557850) (← links)
• Convergent neofunctionalization by positive Darwinian selection after ancient recurrent duplications of the xanthine dehydrogenase gene (Q37089373) (← links)
• Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation (Q37133541) (← links)
• Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans (Q38064334) (← links)
• Drug discovery for hyperuricemia (Q38089866) (← links)
• Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases. (Q38318607) (← links)
• Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase (Q38494677) (← links)
• Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. (Q39349571) (← links)
• The C-terminal peptide plays a role in the formation of an intermediate form during the transition between xanthine dehydrogenase and xanthine oxidase. (Q40197320) (← links)
• Evaluation of the Effectiveness of Xanthine Oxidoreductase Inhibitors on Haemodialysis Patients using a Marginal Structural Model (Q42630143) (← links)
• Xanthine dehydrogenase AtXDH1 from Arabidopsis thaliana is a potent producer of superoxide anions via its NADH oxidase activity (Q43241625) (← links)
• Regulation and biochemistry of mouse molybdo-flavoenzymes. The DBA/2 mouse is selectively deficient in the expression of aldehyde oxidase homologues 1 and 2 and represents a unique source for the purification and characterization of aldehyde oxidase (Q44686501) (← links)
• Redox-Dependent Calpain Signaling in Airway and Pulmonary Vascular Remodeling in COPD. (Q46280869) (← links)
• Mechanism of transition from xanthine dehydrogenase to xanthine oxidase: effect of guanidine-HCL or urea on the activity (Q46502169) (← links)
• Structure and evolution of vertebrate aldehyde oxidases: from gene duplication to gene suppression (Q57097682) (← links)
• Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (Q58075704) (← links)
• Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities (Q88316783) (← links)
• Size-dependent tissue-specific biological effects of core-shell structured Fe3O4@SiO2-NH2 nanoparticles (Q92212695) (← links)